Search
Company
Back
Who is Sysmex?
Back
Sustainability
Back
Products
Back
Diagnostics
Back
Life Science
Back
Solution Provision
Back
Services
Back
QC & Online Services
Back
Document Centre
Back
Academy
Back
Knowledge Centre
Back
Menu
Headquarters
Sysmex Group Companies
Select your local website
December - Emulsion PCR for highly sensitive detection of tumour mutations in peripheral blood
The BEAMing technology involves conversion of single DNA molecules to single magnetic beads, each containing thousands of copies of the sequence of the original DNA molecule. The number of variant DNA molecules in the population can be assessed by staining the beads with fluorescent probes and counting them by using flow cytometry. This way OncoBEAM® blood-based tests deliver a minimally invasive alternative for sensitive real-time molecular diagnostics to improve cancer characterisation and treatment.
